Distinct effects of interleukin-6 and interferon-γ on differentiating human cortical neurons

Brain Behav Immun. 2022 Jul:103:97-108. doi: 10.1016/j.bbi.2022.04.007. Epub 2022 Apr 13.

Abstract

Translational evidence suggests that cytokines involved in maternal immune activation (MIA), such as interleukin-6 (IL-6) and interferon-γ (IFN-γ), can cross the placenta, injure fetal brain, and predispose to neuropsychiatric disorders. To elaborate developmental neuronal sequelae of MIA, we differentiated human pluripotent stem cells to cortical neurons over a two-month period, exposing them to IL-6 or IFN-γ. IL-6 impacted expression of genes regulating extracellular matrix, actin cytoskeleton and TGF-β signaling while IFN-γ impacted genes regulating antigen processing, major histocompatibility complex and endoplasmic reticulum biology. IL-6, but not IFN-γ, altered mitochondrial respiration while IFN-γ, but not IL-6, induced reduction in dendritic spine density. Pre-treatment with folic acid, which has known neuroprotective and anti-inflammatory properties, ameliorated IL-6 effects on mitochondrial respiration and IFN-γ effects on dendritic spine density. These findings suggest distinct mechanisms for how fetal IL-6 and IFN-γ exposure influence risk for neuropsychiatric disorders, and how folic acid can mitigate such risk.

Keywords: Folic acid; Interferon-γ; Interleukin-6; Maternal immune activation; iPSC.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Differentiation
  • Cytokines
  • Folic Acid
  • Humans
  • Interferon-gamma* / pharmacology
  • Interleukin-6* / pharmacology
  • Neurons* / drug effects
  • Pluripotent Stem Cells / cytology

Substances

  • Cytokines
  • Interleukin-6
  • Interferon-gamma
  • Folic Acid